Global | PH | Control | p | |||
---|---|---|---|---|---|---|
80 | 68 | 12 | ||||
Age | Mean ± SD | 72.56 ± 8.1471 | 73.01 ± 8.56 | 70.00 ± 4.59 | p = 0.0847 | |
Gender | Nr (%) | Male | 25 (31.2%) | 20 (29.41) | 5 (41.66) | p = 0.6124 |
Female | 55 (68.7%) | 48 (70.58) | 7 (58.33) | |||
Body mass index | Mean ± SD | 29.81 ± 6.21 | 29.65 ± 6.2807 | 30.70 ± 5.98 | p = 0.5942 | |
WHO | Nr (%) | I | 5 (6.2%) | 0 (0) | 5 (41.66) | p < 0.0001 |
II [PHLHD(12), CTEPH(1), PHCOPD(1)] | 21 (26.2%) | 14 (20.58) | 7 (58.33) | |||
III [PHLHD(27), CTEPH(4), PHCOPD(6)] | 37 (46.2%) | 37 (54.41) | 0 (0) | |||
IV [PHLHD(9), CTEPH(5), PHCOPD(3) | 17 (21.2%) | 17 (25) | 0 (0) | |||
TIMP-4(pg/ml) | Mean ± SD | 2723.88 ± 1352.40 | 2846.62 ± 1399.70 | 2028.38 ± 762.67 | p = 0.0068 | |
MMP-2(ng/ml) | Mean ± SD | 96.12 ± 14.49 | 96.76 ± 14.10 | 92.47 ± 16.76 | p = 0.3479 | |
NT-proBNP *(pg/ml) | Median (mean ± SD) | 2217.50 (4673.21 ± 6430.68) | 2405.00 (5423.47 ± 6703.38) | 411.0000 (421.75 ± 315.37) | p < 0.0001 | |
Total cholesterol (mg/dl) | Mean ± SD | 159.26 ± 48.99 | 155.03 ± 48.66 | 182.91 ± 45.75 | p = 0.0691 | |
Triglycerides * (mg/dl) | Median (mean ± SD) | 103.50 (115.35 ± 54.36) | 103.00 (109.39 ± 46.84) | 116.00 (149.08 ± 79.95) | p = 0.0659 | |
RA size (cm2) | Mean ± SD | 25.86 ± 10.70 | 26.91 ± 11.15 | 19.90 ± 4.51 | p = 0.0006 | |
LA size (cm2) * | Median (mean ± SD) | 30.70 (35.92 ± 29.37) | 31.50 (38.06 ± 31.42) | 24.10 (24.15 ± 5.36) | p = 0.0007 | |
RD base diameter (cm) | Mean ± SD | 48.36 ± 7.89 | 49.31 ± 7.58 | 43.00 ± 7.75 | p = 0.0097 | |
TAPSE (mm) | Mean ± SD | 20.93 ± 4.44 | 20.39 ± 4.36 | 24.00 ± 3.71 | p = 0.0088 | |
sPAP (mmHg) | Mean ± SD | 57.50 ± 21.48 | 62.90 ± 18.19 | 26.94 ± 10.01 | p < 0.0001 |